IBDEI0Y6 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16641,1,3,0)
 ;;=3^997.32
 ;;^UTILITY(U,$J,358.3,16641,1,4,0)
 ;;=4^Post Proc Aspiration Pneumonia
 ;;^UTILITY(U,$J,358.3,16641,2)
 ;;=^340577
 ;;^UTILITY(U,$J,358.3,16642,0)
 ;;=997.39^^84^999^2
 ;;^UTILITY(U,$J,358.3,16642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16642,1,3,0)
 ;;=3^997.39
 ;;^UTILITY(U,$J,358.3,16642,1,4,0)
 ;;=4^Respiratory Complications NEC
 ;;^UTILITY(U,$J,358.3,16642,2)
 ;;=^336693
 ;;^UTILITY(U,$J,358.3,16643,0)
 ;;=278.01^^84^1000^6
 ;;^UTILITY(U,$J,358.3,16643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16643,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,16643,1,4,0)
 ;;=4^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,16643,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,16644,0)
 ;;=327.21^^84^1000^2
 ;;^UTILITY(U,$J,358.3,16644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16644,1,3,0)
 ;;=3^327.21
 ;;^UTILITY(U,$J,358.3,16644,1,4,0)
 ;;=4^Central Primary Sleep Apnea
 ;;^UTILITY(U,$J,358.3,16644,2)
 ;;=^332761
 ;;^UTILITY(U,$J,358.3,16645,0)
 ;;=327.23^^84^1000^7
 ;;^UTILITY(U,$J,358.3,16645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16645,1,3,0)
 ;;=3^327.23
 ;;^UTILITY(U,$J,358.3,16645,1,4,0)
 ;;=4^Obstructive Sleep Apnea
 ;;^UTILITY(U,$J,358.3,16645,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,16646,0)
 ;;=327.26^^84^1000^9
 ;;^UTILITY(U,$J,358.3,16646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16646,1,3,0)
 ;;=3^327.26
 ;;^UTILITY(U,$J,358.3,16646,1,4,0)
 ;;=4^Sleep Hypovent in Oth Diseases
 ;;^UTILITY(U,$J,358.3,16646,2)
 ;;=^332766
 ;;^UTILITY(U,$J,358.3,16647,0)
 ;;=333.94^^84^1000^8
 ;;^UTILITY(U,$J,358.3,16647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16647,1,3,0)
 ;;=3^333.94
 ;;^UTILITY(U,$J,358.3,16647,1,4,0)
 ;;=4^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,16647,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,16648,0)
 ;;=333.99^^84^1000^1
 ;;^UTILITY(U,$J,358.3,16648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16648,1,3,0)
 ;;=3^333.99
 ;;^UTILITY(U,$J,358.3,16648,1,4,0)
 ;;=4^Abnormal Movement Disorder
 ;;^UTILITY(U,$J,358.3,16648,2)
 ;;=^87587
 ;;^UTILITY(U,$J,358.3,16649,0)
 ;;=780.51^^84^1000^5
 ;;^UTILITY(U,$J,358.3,16649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16649,1,3,0)
 ;;=3^780.51
 ;;^UTILITY(U,$J,358.3,16649,1,4,0)
 ;;=4^Insomnia w/ Sleep Apnea NOS
 ;;^UTILITY(U,$J,358.3,16649,2)
 ;;=^332923
 ;;^UTILITY(U,$J,358.3,16650,0)
 ;;=780.52^^84^1000^4
 ;;^UTILITY(U,$J,358.3,16650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16650,1,3,0)
 ;;=3^780.52
 ;;^UTILITY(U,$J,358.3,16650,1,4,0)
 ;;=4^Insomnia NOS
 ;;^UTILITY(U,$J,358.3,16650,2)
 ;;=^332924
 ;;^UTILITY(U,$J,358.3,16651,0)
 ;;=780.53^^84^1000^3
 ;;^UTILITY(U,$J,358.3,16651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16651,1,3,0)
 ;;=3^780.53
 ;;^UTILITY(U,$J,358.3,16651,1,4,0)
 ;;=4^Hypersom w/ Sleep Apnea NOS
 ;;^UTILITY(U,$J,358.3,16651,2)
 ;;=^332925
 ;;^UTILITY(U,$J,358.3,16652,0)
 ;;=780.56^^84^1000^10
 ;;^UTILITY(U,$J,358.3,16652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16652,1,3,0)
 ;;=3^780.56
 ;;^UTILITY(U,$J,358.3,16652,1,4,0)
 ;;=4^Sleep Stage Dysfunctions
 ;;^UTILITY(U,$J,358.3,16652,2)
 ;;=^37528
 ;;^UTILITY(U,$J,358.3,16653,0)
 ;;=117.9^^84^1001^16
 ;;^UTILITY(U,$J,358.3,16653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16653,1,3,0)
 ;;=3^117.9
 ;;^UTILITY(U,$J,358.3,16653,1,4,0)
 ;;=4^Mycoses,Unspec
 ;;^UTILITY(U,$J,358.3,16653,2)
 ;;=^87308
 ;;^UTILITY(U,$J,358.3,16654,0)
 ;;=136.3^^84^1001^17
 ;;^UTILITY(U,$J,358.3,16654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16654,1,3,0)
 ;;=3^136.3
 ;;^UTILITY(U,$J,358.3,16654,1,4,0)
 ;;=4^Pneumocystosis
 ;;
 ;;$END ROU IBDEI0Y6
